108 related articles for article (PubMed ID: 8234901)
21. SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist.
Anthes JC; Chapman RW; Richard C; Eckel S; Corboz M; Hey JA; Fernandez X; Greenfeder S; McLeod R; Sehring S; Rizzo C; Crawley Y; Shih NY; Piwinski J; Reichard G; Ting P; Carruthers N; Cuss FM; Billah M; Kreutner W; Egan RW
Eur J Pharmacol; 2002 Aug; 450(2):191-202. PubMed ID: 12206858
[TBL] [Abstract][Full Text] [Related]
22. Activity of peptide and non-peptide antagonists at peripheral NK1 receptors.
Patacchini R; Santicioli P; Astolfi M; Rovero P; Viti G; Maggi CA
Eur J Pharmacol; 1992 Apr; 215(1):93-8. PubMed ID: 1381319
[TBL] [Abstract][Full Text] [Related]
23. Effect of several bicyclic peptide and cyclic pseudopeptide tachykinin NK2 receptor antagonists in the human isolated ileum and colon.
Patacchini R; Giuliani S; Lazzeri M; Turini A; Quartara L; Maggi CA
Neuropeptides; 1997 Feb; 31(1):71-7. PubMed ID: 9574841
[TBL] [Abstract][Full Text] [Related]
24. Use of selective antagonists for further characterization of tachykinin NK-2, NK-1 and possible "septide-selective" receptors in guinea pig bronchus.
Zeng XP; Burcher E
J Pharmacol Exp Ther; 1994 Sep; 270(3):1295-300. PubMed ID: 7523658
[TBL] [Abstract][Full Text] [Related]
25. Antibronchospastic activity of MEN10,627, a novel tachykinin NK2 receptor antagonist, in guinea-pig airways.
Perretti F; Ballati L; Manzini S; Maggi CA; Evangelista S
Eur J Pharmacol; 1995 Jan; 273(1-2):129-35. PubMed ID: 7737306
[TBL] [Abstract][Full Text] [Related]
26. Effect of YM-44781, YM-44778 and YM-49598, novel tachykinin antagonists, in a drug-induced bladder contraction model.
Choppin A; Groke G; Bringas A; Stepan G; Dillon MP
Pharmacology; 2002 May; 65(2):96-102. PubMed ID: 11937780
[TBL] [Abstract][Full Text] [Related]
27. Affinity of R 396, an NK-2 tachykinin receptor antagonist, for NK-2 receptors in preparations from different species.
Maggi CA; Patacchini R; Astolfi M; Rovero P; Giachetti A; Van Giersbergen PL
Neuropeptides; 1992 Jun; 22(2):93-8. PubMed ID: 1328923
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors.
Giuliani S; Patacchini R; Barbanti G; Turini D; Rovero P; Quartara L; Giachetti A; Maggi CA
J Pharmacol Exp Ther; 1993 Nov; 267(2):590-5. PubMed ID: 8246132
[TBL] [Abstract][Full Text] [Related]
29. Evidence that tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitation and contraction in the circular muscle of guinea-pig duodenum.
Zagorodnyuk V; Santicioli P; Maggi CA; Giachetti A
Br J Pharmacol; 1995 May; 115(2):237-46. PubMed ID: 7545517
[TBL] [Abstract][Full Text] [Related]
30. Characterization of tachykinin NK2 receptor on dog proximal colon. Antagonism by MEN 10,627 and SR 48,968.
Parlani M; Conte B; Cirillo R; Manzini S
Eur J Pharmacol; 1996 Dec; 318(2-3):419-24. PubMed ID: 9016933
[TBL] [Abstract][Full Text] [Related]
31. Activity of SR 142801 at peripheral tachykinin receptors.
Patacchini R; Barthò L; Holzer P; Maggi CA
Eur J Pharmacol; 1995 May; 278(1):17-25. PubMed ID: 7545122
[TBL] [Abstract][Full Text] [Related]
32. Tachykinin receptors mediate atropine-resistant rat duodenal reflex contractions in vivo.
Giuliani S; Tramontana M; Lecci A; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):327-35. PubMed ID: 8878063
[TBL] [Abstract][Full Text] [Related]
33. Characterization and autoradiographic localization of tachykinin receptors in rat gastric fundus.
Mussap CJ; Burcher E
J Pharmacol Exp Ther; 1993 Aug; 266(2):1043-53. PubMed ID: 8394903
[TBL] [Abstract][Full Text] [Related]
34. Isolation and pharmacological characterization of a hamster urinary bladder neurokinin A receptor cDNA.
Aharony D; Little J; Thomas C; Powell S; Berry D; Graham A
Mol Pharmacol; 1994 Jan; 45(1):9-19. PubMed ID: 8302285
[TBL] [Abstract][Full Text] [Related]
35. Tachykinin receptors in the guinea-pig isolated bronchi.
Maggi CA; Patacchini R; Quartara L; Rovero P; Santicioli P
Eur J Pharmacol; 1991 May; 197(2-3):167-74. PubMed ID: 1717290
[TBL] [Abstract][Full Text] [Related]
36. Evidence against a peripheral role of tachykinins in the initiation of micturition reflex in rats.
Lecci A; Giuliani S; Patacchini R; Maggi CA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1327-32. PubMed ID: 8383746
[TBL] [Abstract][Full Text] [Related]
37. Mutagenesis at the human tachykinin NK(2) receptor to define the binding site of a novel class of antagonists.
Meini S; Bellucci F; Catalani C; Cucchi P; Patacchini R; Rotondaro L; Altamura M; Giuliani S; Giolitti A; Maggi CA
Eur J Pharmacol; 2004 Mar; 488(1-3):61-9. PubMed ID: 15044036
[TBL] [Abstract][Full Text] [Related]
38. Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: evidence for species differences.
Belvisi MG; Patacchini R; Barnes PJ; Maggi CA
Br J Pharmacol; 1994 Jan; 111(1):103-10. PubMed ID: 7516799
[TBL] [Abstract][Full Text] [Related]
39. Role of C-terminal amidation on the biological activity of neurokinin A derivatives with agonist and antagonist properties.
Patacchini R; Quartara L; Rovero P; Goso C; Maggi CA
J Pharmacol Exp Ther; 1993 Jan; 264(1):17-21. PubMed ID: 8380857
[TBL] [Abstract][Full Text] [Related]
40. [3H][beta-Ala8]neurokinin A-(4-10): a novel, selective radioligand for the tachykinin NK2 receptor.
Goso C; Astolfi M; Parlani M; Manzini S
Eur J Pharmacol; 1995 Dec; 294(1):239-45. PubMed ID: 8788437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
